Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
266 results found
2012 ∙ El-Makhzangy, A. M. Ismail, N. M. Galal, S. B. Sobhy, T. S. Hegazy, A. A.
Can vaccination against pneumococci prevent otitis media with effusion?
Newborn Children Adolescents Pneumococcal disease Efficacy/effectiveness
Rating:
Critically low
2012 ∙ Farkouh, R. A. Klok, R. M. Postma, M. J. Roberts, C. S. Strutton, D. R.
Cost-effectiveness models of pneumococcal conjugate vaccines: variability and impact of modeling assumptions
All age groups Pneumococcal disease Economic aspects Coverage Efficacy/effectiveness
Rating:
Not applicable
2012 ∙ Taylor, S. Marchisio, P. Vergison, A. Harriague, J. Hausdorff, W. P. Haggard, M.
Impact of pneumococcal conjugate vaccination on otitis media: A systematic review
Newborn Children Adolescents Pneumococcal disease Efficacy/effectiveness
Rating:
Critically low
2012 ∙ Sehatzadeh, S.
Influenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease (COPD): an evidence-based review
Adults Older adults Influenza Pneumococcal disease Efficacy/effectiveness Safety
Rating:
Critically low
2012 ∙ Lau, D. Hu, J. Majumdar, S. R. Storie, D. A. Rees, S. E. Johnson, J. A.
Interventions to improve influenza and pneumococcal vaccination rates among community-dwelling adults: a systematic review and meta-analysis
Adults Older adults Influenza Pneumococcal disease Coverage
Rating:
Not applicable
2012 ∙ Makris, M. C. Polyzos, K. A. Mavros, M. N. Athanasiou, S. Rafailidis, P. I. Falagas, M. E.
Safety of hepatitis B, pneumococcal polysaccharide and meningococcal polysaccharide vaccines in pregnancy: A systematic review
Pregnant women Meningococcal disease Hepatitis B Pneumococcal disease Safety
Rating:
Critically low
2012 ∙ WHO
Pneumococcal vaccines: WHO position paper
Position paper Pneumococcal disease
Download:
2012 ∙ ACIP
Licensure of 13-Valent Pneumococcal Conjugate Vaccine for Adults Aged 50 Years and Older
Recommendation Americas United States of America Pneumococcal disease
Download:
2012 ∙ ACIP
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults with Immunocompromising Conditions
Recommendation Americas United States of America Pneumococcal disease
Download:
2011 ∙ Scott, P. Rutjes, A. W. S. Bermetz, L. Robert, N. Scott, S. Lourenço, T. Egger, M. Low, N.
Comparing pneumococcal conjugate vaccine schedules based on 3 and 2 primary doses: Systematic review and meta-analysis
Newborn Children Adolescents Pneumococcal disease Efficacy/effectiveness Administration
Rating:
Critically low
Loading...